Provided by Tiger Fintech (Singapore) Pte. Ltd.

Context Therapeutics Inc.

0.8192
+0.02423.04%
Post-market: 0.8100-0.0092-1.12%17:39 EDT
Volume:46.21K
Turnover:38.62K
Market Cap:73.49M
PE:-1.14
High:0.8622
Open:0.8000
Low:0.8000
Close:0.7950
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
25 Feb

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT Newswires Live
·
15 Jan

BRIEF-Context Therapeutics Says First Patient Dosed In The Phase 1 Clinical Trial Of CTIM-76

Reuters
·
15 Jan

Context Therapeutics Doses First Patient in Phase 1 Cancer Treatment Trial

MT Newswires Live
·
15 Jan

Context Therapeutics Advances CTIM-76 in Clinical Pipeline

TIPRANKS
·
15 Jan

Context doses first patient in Phase 1 clinical trial evaluating CTIM-76

TIPRANKS
·
15 Jan

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of Ctim-76

THOMSON REUTERS
·
15 Jan

BRIEF-Context Therapeutics Appoints Andy Pasternak As Chairman Of The Board Of Directors

Reuters
·
13 Jan

Context Therapeutics Names Andy Pasternak Board Chairman

MT Newswires Live
·
13 Jan

Context Therapeutics Inc - Richard Berman Steps Down From Context Board

THOMSON REUTERS
·
13 Jan

Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

THOMSON REUTERS
·
13 Jan

Context Therapeutics Initiated at Market Outperform by JMP Securities

Dow Jones
·
08 Jan

Context Therapeutics Inc - Enters Sales Agreement With Leerink Partners

THOMSON REUTERS
·
03 Dec 2024

Context Therapeutics Inc - Under Sales Agreement, May Offer & Sell up to $75 Million in Common Stock

THOMSON REUTERS
·
03 Dec 2024